Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement, ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Zacks.com on MSN21h
Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Labcorp Holdings (LH – Research Report), ...
Canaccord raised the firm’s price target on Nevro (NVRO) to $5.85 from $4 and keeps a Hold rating on the shares. The firm noted Globus Medical ...
Zacks.com on MSN15h
Ecolab Set to Report Q4 Earnings: What's in Store for the Stock?Ecolab, Inc. ECL is scheduled to report fourth-quarter 2024 results on Feb. 11, 2025, before the opening bell. In the last ...
Globus Medical, a leading musculoskeletal solutions company, has announced its acquisition of Nevro Corp, a global medical ...
MyChesCo on MSN21h
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million DealGlobus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp. (NYSE: NVRO) in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback